Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas

Publisher DOI
PubMed ID
21680696
Description
Glucagon-like peptide-1 (GLP-1) receptor imaging is superior to somatostatin receptor subtype 2 (sst(2)) imaging in localizing benign insulinomas. Here, the role of GLP-1 and sst(2) receptor imaging in the management of malignant insulinoma patients was investigated.
Date of Publication
2011
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Wild, Damian
Caplin, Martyn E
Kurzawinski, Tom R
Forrer, Flavio
Brändle, Michael
Seufert, Jochen
Weber, Wolfgang A
Bomanji, Jamshed
Ell, Peter J
Additional Credits
Series
Journal of nuclear medicine
Publisher
Society of Nuclear Medicine
ISSN
0161-5505
Access(Rights)
metadata.only
Show full item